EPHA2 and neoplasm: Yu et al. showed vaccinia virus armed with BiTE made up of two single-chain variable fragments for CD3 and tumor cell surface antigen EphA2 had potentially killed tumor cells; they also showed an abscopal effect by T-cell-mediated activation and tumor lysis [88].